ARID1A and pancreatic neoplasm: We found increased infiltration of various immune cells including T cells, granulocytes, neutrophils and B cells in the KAR tumours, consisting with the finding that ARID1A‐mutated pancreatic cancer patients are more responsive to immune checkpoint blockade.